 | • レポートコード：QYR2104Z4046 • 出版社/出版日：QYResearch / 2021年4月15日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、壊死性筋膜炎のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（静脈内抗生物質、手術、高圧酸素治療）、用途別市場規模（病院＆クリニック、外科センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・壊死性筋膜炎の市場動向 ・企業の競争状況、市場シェア ・壊死性筋膜炎の種類別市場規模（静脈内抗生物質、手術、高圧酸素治療） ・壊死性筋膜炎の用途別市場規模（病院＆クリニック、外科センター） ・壊死性筋膜炎の北米市場規模2016-2027（アメリカ、カナダ） ・壊死性筋膜炎のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・壊死性筋膜炎のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・壊死性筋膜炎の中南米市場規模2016-2027（メキシコ、ブラジル） ・壊死性筋膜炎の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Wockhardt、Atox Bio、Teva Pharmaceutical Industries、Basilea Pharmaceutica、Melinta Therapeutics） ・結論 |
Necrotizing fasciitis (NF), commonly known as flesh-eating disease, is an infection that results in the death of the body’s soft tissue. It is a severe disease of sudden onset that spreads rapidly. Symptoms include red or purple skin in the affected area, severe pain, fever, and vomiting. The most commonly affected areas are the limbs and perineum.
Necrotizing fasciitis affects 0.4 to 1.0 person per 100,000 per year. Both sexes are affected equally. It becomes more common among older people and is very rare in children. Surgical debridement (cutting away affected tissue) is the mainstay of treatment for necrotizing fasciitis. Early medical treatment is often presumptive; thus, antibiotics should be started as soon as this condition is suspected. Cultures are taken to determine appropriate antibiotic coverage, and antibiotics may be changed when culture results are obtained. Besides blood pressure control and hydration, support should be initiated for those with unstable vital signs and low urine output.
Market Analysis and Insights: Global Necrotizing Fasciitis Market
The global Necrotizing Fasciitis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Necrotizing Fasciitis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Necrotizing Fasciitis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Necrotizing Fasciitis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Necrotizing Fasciitis market.
Global Necrotizing Fasciitis Scope and Market Size
Necrotizing Fasciitis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Necrotizing Fasciitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Intravenous Antibiotics
Surgery
Hyperbaric Oxygen Treatment
Segment by Application
Hospital & Clinics
Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Wockhardt
Atox Bio
Teva Pharmaceutical Industries
Basilea Pharmaceutica
Melinta Therapeutics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Necrotizing Fasciitis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous Antibiotics
1.2.3 Surgery
1.2.4 Hyperbaric Oxygen Treatment
1.3 Market by Application
1.3.1 Global Necrotizing Fasciitis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital & Clinics
1.3.3 Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Necrotizing Fasciitis Market Perspective (2016-2027)
2.2 Necrotizing Fasciitis Growth Trends by Regions
2.2.1 Necrotizing Fasciitis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Necrotizing Fasciitis Historic Market Share by Regions (2016-2021)
2.2.3 Necrotizing Fasciitis Forecasted Market Size by Regions (2022-2027)
2.3 Necrotizing Fasciitis Industry Dynamic
2.3.1 Necrotizing Fasciitis Market Trends
2.3.2 Necrotizing Fasciitis Market Drivers
2.3.3 Necrotizing Fasciitis Market Challenges
2.3.4 Necrotizing Fasciitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Necrotizing Fasciitis Players by Revenue
3.1.1 Global Top Necrotizing Fasciitis Players by Revenue (2016-2021)
3.1.2 Global Necrotizing Fasciitis Revenue Market Share by Players (2016-2021)
3.2 Global Necrotizing Fasciitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Necrotizing Fasciitis Revenue
3.4 Global Necrotizing Fasciitis Market Concentration Ratio
3.4.1 Global Necrotizing Fasciitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Necrotizing Fasciitis Revenue in 2020
3.5 Necrotizing Fasciitis Key Players Head office and Area Served
3.6 Key Players Necrotizing Fasciitis Product Solution and Service
3.7 Date of Enter into Necrotizing Fasciitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Necrotizing Fasciitis Breakdown Data by Type
4.1 Global Necrotizing Fasciitis Historic Market Size by Type (2016-2021)
4.2 Global Necrotizing Fasciitis Forecasted Market Size by Type (2022-2027)
5 Necrotizing Fasciitis Breakdown Data by Application
5.1 Global Necrotizing Fasciitis Historic Market Size by Application (2016-2021)
5.2 Global Necrotizing Fasciitis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Necrotizing Fasciitis Market Size (2016-2027)
6.2 North America Necrotizing Fasciitis Market Size by Type
6.2.1 North America Necrotizing Fasciitis Market Size by Type (2016-2021)
6.2.2 North America Necrotizing Fasciitis Market Size by Type (2022-2027)
6.2.3 North America Necrotizing Fasciitis Market Size by Type (2016-2027)
6.3 North America Necrotizing Fasciitis Market Size by Application
6.3.1 North America Necrotizing Fasciitis Market Size by Application (2016-2021)
6.3.2 North America Necrotizing Fasciitis Market Size by Application (2022-2027)
6.3.3 North America Necrotizing Fasciitis Market Size by Application (2016-2027)
6.4 North America Necrotizing Fasciitis Market Size by Country
6.4.1 North America Necrotizing Fasciitis Market Size by Country (2016-2021)
6.4.2 North America Necrotizing Fasciitis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Necrotizing Fasciitis Market Size (2016-2027)
7.2 Europe Necrotizing Fasciitis Market Size by Type
7.2.1 Europe Necrotizing Fasciitis Market Size by Type (2016-2021)
7.2.2 Europe Necrotizing Fasciitis Market Size by Type (2022-2027)
7.2.3 Europe Necrotizing Fasciitis Market Size by Type (2016-2027)
7.3 Europe Necrotizing Fasciitis Market Size by Application
7.3.1 Europe Necrotizing Fasciitis Market Size by Application (2016-2021)
7.3.2 Europe Necrotizing Fasciitis Market Size by Application (2022-2027)
7.3.3 Europe Necrotizing Fasciitis Market Size by Application (2016-2027)
7.4 Europe Necrotizing Fasciitis Market Size by Country
7.4.1 Europe Necrotizing Fasciitis Market Size by Country (2016-2021)
7.4.2 Europe Necrotizing Fasciitis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Necrotizing Fasciitis Market Size (2016-2027)
8.2 Asia-Pacific Necrotizing Fasciitis Market Size by Type
8.2.1 Asia-Pacific Necrotizing Fasciitis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Necrotizing Fasciitis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Necrotizing Fasciitis Market Size by Type (2016-2027)
8.3 Asia-Pacific Necrotizing Fasciitis Market Size by Application
8.3.1 Asia-Pacific Necrotizing Fasciitis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Necrotizing Fasciitis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Necrotizing Fasciitis Market Size by Application (2016-2027)
8.4 Asia-Pacific Necrotizing Fasciitis Market Size by Region
8.4.1 Asia-Pacific Necrotizing Fasciitis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Necrotizing Fasciitis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Necrotizing Fasciitis Market Size (2016-2027)
9.2 Latin America Necrotizing Fasciitis Market Size by Type
9.2.1 Latin America Necrotizing Fasciitis Market Size by Type (2016-2021)
9.2.2 Latin America Necrotizing Fasciitis Market Size by Type (2022-2027)
9.2.3 Latin America Necrotizing Fasciitis Market Size by Type (2016-2027)
9.3 Latin America Necrotizing Fasciitis Market Size by Application
9.3.1 Latin America Necrotizing Fasciitis Market Size by Application (2016-2021)
9.3.2 Latin America Necrotizing Fasciitis Market Size by Application (2022-2027)
9.3.3 Latin America Necrotizing Fasciitis Market Size by Application (2016-2027)
9.4 Latin America Necrotizing Fasciitis Market Size by Country
9.4.1 Latin America Necrotizing Fasciitis Market Size by Country (2016-2021)
9.4.2 Latin America Necrotizing Fasciitis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Necrotizing Fasciitis Market Size (2016-2027)
10.2 Middle East & Africa Necrotizing Fasciitis Market Size by Type
10.2.1 Middle East & Africa Necrotizing Fasciitis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Necrotizing Fasciitis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Necrotizing Fasciitis Market Size by Type (2016-2027)
10.3 Middle East & Africa Necrotizing Fasciitis Market Size by Application
10.3.1 Middle East & Africa Necrotizing Fasciitis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Necrotizing Fasciitis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Necrotizing Fasciitis Market Size by Application (2016-2027)
10.4 Middle East & Africa Necrotizing Fasciitis Market Size by Country
10.4.1 Middle East & Africa Necrotizing Fasciitis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Necrotizing Fasciitis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Necrotizing Fasciitis Introduction
11.1.4 Merck Revenue in Necrotizing Fasciitis Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Wockhardt
11.2.1 Wockhardt Company Details
11.2.2 Wockhardt Business Overview
11.2.3 Wockhardt Necrotizing Fasciitis Introduction
11.2.4 Wockhardt Revenue in Necrotizing Fasciitis Business (2016-2021)
11.2.5 Wockhardt Recent Development
11.3 Atox Bio
11.3.1 Atox Bio Company Details
11.3.2 Atox Bio Business Overview
11.3.3 Atox Bio Necrotizing Fasciitis Introduction
11.3.4 Atox Bio Revenue in Necrotizing Fasciitis Business (2016-2021)
11.3.5 Atox Bio Recent Development
11.4 Teva Pharmaceutical Industries
11.4.1 Teva Pharmaceutical Industries Company Details
11.4.2 Teva Pharmaceutical Industries Business Overview
11.4.3 Teva Pharmaceutical Industries Necrotizing Fasciitis Introduction
11.4.4 Teva Pharmaceutical Industries Revenue in Necrotizing Fasciitis Business (2016-2021)
11.4.5 Teva Pharmaceutical Industries Recent Development
11.5 Basilea Pharmaceutica
11.5.1 Basilea Pharmaceutica Company Details
11.5.2 Basilea Pharmaceutica Business Overview
11.5.3 Basilea Pharmaceutica Necrotizing Fasciitis Introduction
11.5.4 Basilea Pharmaceutica Revenue in Necrotizing Fasciitis Business (2016-2021)
11.5.5 Basilea Pharmaceutica Recent Development
11.6 Melinta Therapeutics
11.6.1 Melinta Therapeutics Company Details
11.6.2 Melinta Therapeutics Business Overview
11.6.3 Melinta Therapeutics Necrotizing Fasciitis Introduction
11.6.4 Melinta Therapeutics Revenue in Necrotizing Fasciitis Business (2016-2021)
11.6.5 Melinta Therapeutics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Necrotizing Fasciitis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous Antibiotics
Table 3. Key Players of Surgery
Table 4. Key Players of Hyperbaric Oxygen Treatment
Table 5. Global Necrotizing Fasciitis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Necrotizing Fasciitis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Necrotizing Fasciitis Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Necrotizing Fasciitis Market Share by Regions (2016-2021)
Table 9. Global Necrotizing Fasciitis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Necrotizing Fasciitis Market Share by Regions (2022-2027)
Table 11. Necrotizing Fasciitis Market Trends
Table 12. Necrotizing Fasciitis Market Drivers
Table 13. Necrotizing Fasciitis Market Challenges
Table 14. Necrotizing Fasciitis Market Restraints
Table 15. Global Necrotizing Fasciitis Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Necrotizing Fasciitis Market Share by Players (2016-2021)
Table 17. Global Top Necrotizing Fasciitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotizing Fasciitis as of 2020)
Table 18. Ranking of Global Top Necrotizing Fasciitis Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Necrotizing Fasciitis Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Necrotizing Fasciitis Product Solution and Service
Table 22. Date of Enter into Necrotizing Fasciitis Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Necrotizing Fasciitis Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Necrotizing Fasciitis Revenue Market Share by Type (2016-2021)
Table 26. Global Necrotizing Fasciitis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Necrotizing Fasciitis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Necrotizing Fasciitis Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Necrotizing Fasciitis Revenue Market Share by Application (2016-2021)
Table 30. Global Necrotizing Fasciitis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Necrotizing Fasciitis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Necrotizing Fasciitis Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Necrotizing Fasciitis Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Necrotizing Fasciitis Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Necrotizing Fasciitis Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Necrotizing Fasciitis Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Necrotizing Fasciitis Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Necrotizing Fasciitis Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Necrotizing Fasciitis Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Necrotizing Fasciitis Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Necrotizing Fasciitis Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Necrotizing Fasciitis Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Necrotizing Fasciitis Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Necrotizing Fasciitis Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Necrotizing Fasciitis Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Necrotizing Fasciitis Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Necrotizing Fasciitis Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Necrotizing Fasciitis Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Necrotizing Fasciitis Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Necrotizing Fasciitis Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Necrotizing Fasciitis Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Necrotizing Fasciitis Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Necrotizing Fasciitis Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Necrotizing Fasciitis Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Necrotizing Fasciitis Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Necrotizing Fasciitis Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Necrotizing Fasciitis Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Necrotizing Fasciitis Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Necrotizing Fasciitis Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Necrotizing Fasciitis Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Necrotizing Fasciitis Market Size by Country (2022-2027) & (US$ Million)
Table 62. Merck Company Details
Table 63. Merck Business Overview
Table 64. Merck Necrotizing Fasciitis Product
Table 65. Merck Revenue in Necrotizing Fasciitis Business (2016-2021) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Wockhardt Company Details
Table 68. Wockhardt Business Overview
Table 69. Wockhardt Necrotizing Fasciitis Product
Table 70. Wockhardt Revenue in Necrotizing Fasciitis Business (2016-2021) & (US$ Million)
Table 71. Wockhardt Recent Development
Table 72. Atox Bio Company Details
Table 73. Atox Bio Business Overview
Table 74. Atox Bio Necrotizing Fasciitis Product
Table 75. Atox Bio Revenue in Necrotizing Fasciitis Business (2016-2021) & (US$ Million)
Table 76. Atox Bio Recent Development
Table 77. Teva Pharmaceutical Industries Company Details
Table 78. Teva Pharmaceutical Industries Business Overview
Table 79. Teva Pharmaceutical Industries Necrotizing Fasciitis Product
Table 80. Teva Pharmaceutical Industries Revenue in Necrotizing Fasciitis Business (2016-2021) & (US$ Million)
Table 81. Teva Pharmaceutical Industries Recent Development
Table 82. Basilea Pharmaceutica Company Details
Table 83. Basilea Pharmaceutica Business Overview
Table 84. Basilea Pharmaceutica Necrotizing Fasciitis Product
Table 85. Basilea Pharmaceutica Revenue in Necrotizing Fasciitis Business (2016-2021) & (US$ Million)
Table 86. Basilea Pharmaceutica Recent Development
Table 87. Melinta Therapeutics Company Details
Table 88. Melinta Therapeutics Business Overview
Table 89. Melinta Therapeutics Necrotizing Fasciitis Product
Table 90. Melinta Therapeutics Revenue in Necrotizing Fasciitis Business (2016-2021) & (US$ Million)
Table 91. Melinta Therapeutics Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Necrotizing Fasciitis Market Share by Type: 2020 VS 2027
Figure 2. Intravenous Antibiotics Features
Figure 3. Surgery Features
Figure 4. Hyperbaric Oxygen Treatment Features
Figure 5. Global Necrotizing Fasciitis Market Share by Application: 2020 VS 2027
Figure 6. Hospital & Clinics Case Studies
Figure 7. Surgical Centers Case Studies
Figure 8. Necrotizing Fasciitis Report Years Considered
Figure 9. Global Necrotizing Fasciitis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Necrotizing Fasciitis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Necrotizing Fasciitis Market Share by Regions: 2020 VS 2027
Figure 12. Global Necrotizing Fasciitis Market Share by Regions (2022-2027)
Figure 13. Global Necrotizing Fasciitis Market Share by Players in 2020
Figure 14. Global Top Necrotizing Fasciitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Necrotizing Fasciitis as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Necrotizing Fasciitis Revenue in 2020
Figure 16. Global Necrotizing Fasciitis Revenue Market Share by Type (2016-2021)
Figure 17. Global Necrotizing Fasciitis Revenue Market Share by Type (2022-2027)
Figure 18. North America Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Necrotizing Fasciitis Market Share by Type (2016-2027)
Figure 20. North America Necrotizing Fasciitis Market Share by Application (2016-2027)
Figure 21. North America Necrotizing Fasciitis Market Share by Country (2016-2027)
Figure 22. United States Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Necrotizing Fasciitis Market Share by Type (2016-2027)
Figure 26. Europe Necrotizing Fasciitis Market Share by Application (2016-2027)
Figure 27. Europe Necrotizing Fasciitis Market Share by Country (2016-2027)
Figure 28. Germany Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Necrotizing Fasciitis Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Necrotizing Fasciitis Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Necrotizing Fasciitis Market Share by Region (2016-2027)
Figure 38. China Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Necrotizing Fasciitis Market Share by Type (2016-2027)
Figure 46. Latin America Necrotizing Fasciitis Market Share by Application (2016-2027)
Figure 47. Latin America Necrotizing Fasciitis Market Share by Country (2016-2027)
Figure 48. Mexico Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Necrotizing Fasciitis Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Necrotizing Fasciitis Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Necrotizing Fasciitis Market Share by Country (2016-2027)
Figure 54. Turkey Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Necrotizing Fasciitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Necrotizing Fasciitis Business (2016-2021)
Figure 58. Wockhardt Revenue Growth Rate in Necrotizing Fasciitis Business (2016-2021)
Figure 59. Atox Bio Revenue Growth Rate in Necrotizing Fasciitis Business (2016-2021)
Figure 60. Teva Pharmaceutical Industries Revenue Growth Rate in Necrotizing Fasciitis Business (2016-2021)
Figure 61. Basilea Pharmaceutica Revenue Growth Rate in Necrotizing Fasciitis Business (2016-2021)
Figure 62. Melinta Therapeutics Revenue Growth Rate in Necrotizing Fasciitis Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed